13,120
Total Claims
$1.1M
Drug Cost
857
Beneficiaries
$1,232
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-13%
Cost per patient vs peers
$1,232 vs $1,411 avg
+5%
Brand preference vs peers
11.1% vs 10.6% avg
Brand vs Generic
89% generic
Brand: 1,456 claims · $806K
Generic: 11,620 claims · $248K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 81 | $132K |
| Apixaban | 86 | $109K |
| Sitagliptin Phosphate | 57 | $75K |
| Dulaglutide | 32 | $62K |
| Empagliflozin | 27 | $47K |
| Fluticasone Propion/Salmeterol | 52 | $47K |
| Rivaroxaban | 38 | $41K |
| Semaglutide | 20 | $34K |
| Atorvastatin Calcium | 1,579 | $23K |
| Fluticasone Propion/Salmeterol | 38 | $19K |
| Sitagliptin Phos/Metformin Hcl | 16 | $18K |
| Dapagliflozin Propanediol | 11 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $16K |
| Levothyroxine Sodium | 915 | $15K |
| Insulin Lispro Protamin/Lispro | 12 | $15K |
Prescribing Profile
Patient Profile
75
Avg Age
60%
Female
0.83
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data